European agency highlights blood clot risks from Pfizer's arthritis drug
Pfizer Inc's rheumatoid arthritis drug Xeljanz could increase the risk of blood clots in the lungs and in deep veins, the European Medicines Agency (EMA) said on Thursday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Arthritis | European Medicines Agency (EMA) | Health | Pfizer | Rheumatoid Arthritis | Rheumatology